Clinical acceptability study of micronized purified flavonoid fraction 1000 mg tablets versus 500 mg tablets in patients suffering acute hemorrhoidal disease

Shelygin Yuri; Krivokapic Zoran; Frolov S. A.; Kostarev I. V.; Astashov V. L.; Vasiliev S. V.; Lakhin A. V.; Rodoman G. V.; Soloviev A. O.; Stoyko Y. M.; Khitaryan A. G.; Nechay I. A.

首页> 外文期刊>Current medical research and opinion >Clinical acceptability study of micronized purified flavonoid fraction 1000 mg tablets versus 500 mg tablets in patients suffering acute hemorrhoidal disease

【24h】

Clinical acceptability study of micronized purified flavonoid fraction 1000 mg tablets versus 500 mg tablets in patients suffering acute hemorrhoidal disease

机译：微粉状纯化黄酮类成分1000毫克片剂与500毫克片剂在急性痔疮患者中的临床可接受性研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: To compare the clinical acceptability of micronized purified flavonoid fraction (MPFF) 1000 mg with MPFF 500 mg tablets, administered at the same daily dose in patients suffering non-complicated acute hemorrhoids.

机译：目的：比较以每日相同剂量每日服用同一剂量的1000毫克MPFF和500毫克的纯化的类黄酮微粉的临床可接受性。

著录项

来源
《Current medical research and opinion》 |2016年第11期|共6页
作者
Shelygin Yuri; Krivokapic Zoran; Frolov S. A.; Kostarev I. V.; Astashov V. L.; Vasiliev S. V.; Lakhin A. V.; Rodoman G. V.; Soloviev A. O.; Stoyko Y. M.; Khitaryan A. G.; Nechay I. A.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词
Acceptability; Anal pain; Bleeding; Hemorrhoidal disease; MPFF;

机译：可接受性;肛门疼痛;出血;痔疮;MPFF;

相似文献

外文文献
中文文献
专利

1. Clinical acceptability study of micronized purified flavonoid fraction 1000 mg tablets versus 500 mg tablets in patients suffering acute hemorrhoidal disease [J] . Shelygin Yuri, Krivokapic Zoran, Frolov S. A., Current medical research and opinion . 2016,第11期

机译：微粉状纯化黄酮类成分1000毫克片剂与500毫克片剂在急性痔疮患者中的临床可接受性研究
2. Clinical acceptability study of once-daily versus twice-daily micronized purified flavonoid fraction in patients with symptomatic chronic venous disease: a randomized controlled trial [J] . Kirienko Alexander, Radak Djordje International angiology: A journal of the International Union of Angiology . 2016,第4期

机译：有症状的慢性静脉疾病患者每日一次与每日两次微粉化纯化黄酮含量的临床可接受性研究：一项随机对照试验
3. Analysis of the effects of micronized purified flavonoid fraction versus placebo on symptoms and quality of life in patients suffering from chronic venous disease: from a prospective randomized trial [J] . Rabe E., Agus G. B., Roztocil K. International angiology: A journal of the International Union of Angiology . 2015,第5期

机译：微粉化纯化黄酮类成分与安慰剂对慢性静脉疾病患者症状和生活质量的影响分析：一项前瞻性随机试验
4. Mixed-method feasibility study comparing the outpatient assessment of burn patients using a tablet device versus the usual face-to-face encounter. [D] . Mitchell, Suzanne Stewart. 2015

机译：混合方法可行性研究，比较了使用平板电脑设备对烧伤患者的门诊评估与通常面对面的接触。
5. Role of a Micronized Purified Flavonoid Fraction as an Adjuvant Treatment to Rubber Band Ligation for the Treatment of Patients With Hemorrhoidal Disease: A Longitudinal Cohort Study [O] . Ana Célia Caetano, Catarina Cunha, Bruno Arroja, 2019

机译：纯化的类黄酮微粉作为橡皮筋结扎术辅助治疗痔疮患者的作用：一项纵向队列研究
6. Clinical acceptability study in patients suffering from chronic venous disease (CVD) comparing micronized purified flavonoid fraction (MPFF) 1000 mg, one tablet daily, to MPFF 500 mg tablet twice a day [O] . Alexander Kirienko 2014

机译：患有慢性静脉疾病（CVD）患者的临床可接受性研究比较微粉化纯化的黄酮馏分（MPFF）1000毫克，每日一片，一种片剂，每天两次PMF 500mg片剂

Clinical acceptability study of micronized purified flavonoid fraction 1000 mg tablets versus 500 mg tablets in patients suffering acute hemorrhoidal disease

摘要

著录项

相似文献

相关主题

期刊订阅